Time Warner Cable (OTC: TWCA) has set its 2007 growth targets ahead of its formal stock launch. The shares are still trading under the symbol TWCA on the OTC market on a "when issued" basis. The stock should start trading as TWC around March 1.
The company, a separately traded division of Time Warner Inc. (NYSE: TWX), is predicting $800 million to $1 billion in free cash flow for the year. TWC expects revenue to grow in the mid-to-high thirties range from a base of $11.8 billion and expects OIBDA to grow in the mid-to-high thirties percentage range from a base of $4.2 billion.
In this initial release, the company offers its base rates on the most current numbers: it has 14.6 million customers for various packages; 13.4 million are basic video subscribers and 6 million purchase more than 1 service. The company will give more formal details at its business update conference call at 10 AM EST.
TWCA shares were hit in the market malaise pretty hard yesterday, closing down almost $4 to a new "when-issued" low of $37.80, down from its year to date highs of $44. Time Warner Inc. also saw shares fall hard down almost $1 to $20.21 yesterday. Shares of TWX are up 19 cents to $20.40 currently and TWCA is down 50 cents to $37.30 as of 11 a.m.
Jon Ogg is a partner in 24/7 Wall St., LLC; he does not own securities in the companies he covers.
Last updated: February 09, 2012: 06:43 PM
Hot Stocks
DailyFinance Headlines
- Bonds Are a 'Safe' Investment: A Big Lie Gets Even Bigger
- Why Groupon Will Never Be Great Again
- Why Used Car Bargains Are Getting Harder to Find
- 5 Reasons Facebook Stock May Be a Better Buy Than You Think
- Department Stores Reveal Top Selling Valentine's Gifts
Benzinga Headlines
- How to Profit off Addicts
- The Pepsi Challenge for 8,700 People is to Find a New Job
- How to Profit From Surging Chinese Prices
- Credit Suisse is the Latest Swiss Bank to Disappoint
- Vodafone Misses Quarterly Revenue
TheFlyOnTheWall.com Headlines
- Pitney Bowes will be more aggressive in marketing throughout 2012
- NeurogesX announces AADPAC did not recommend approval for Qutenza
- Flowers Foods sees FY12 CapEx $65M-$75M
- Flowers Foods sees FY12 EPS 96c vs. consensus $1.11
- Flowers Foods reports Q4 EPS 17c vs. consensus 21c
BioHealth Investor Headlines
- Can Human Genome Really Double Its Stock Price? (HGSI)
- Alimera Implosion Analysis, What Is Next (ALIM, PSDV)
- Implosion Analysis For Targacept… What Lies Ahead? (TRGT, AZN)
- Rare Analyst Calls With Huge Upside in Vical and VIVUS (VICL, VVUS, BMY)
- Top Biotechs With Upside Ahead of Earnings (GILD, AMLN, ARIA, INCY, JAZZ, DNDN, HGSI, ILMN, AMGN, CELG, BIIB, BMRN, LIFE, REGN, AMLN, CBST, ONXX, THRX, VPHM)
WalletPop Headlines
- Bonds Are a 'Safe' Investment: A Big Lie Gets Even Bigger
- Why Groupon Will Never Be Great Again
- Why Used Car Bargains Are Getting Harder to Find
- 5 Reasons Facebook Stock May Be a Better Buy Than You Think
- Department Stores Reveal Top Selling Valentine's Gifts
My Portfolios
Track your stocks here!
Find out why more people track their portfolios on AOL Money & Finance then anywhere else.
BloggingStocks Partners
More from AOL Money & Finance
- Business News
- Stock Screener
- Stock Quotes
- Stock Charts
- Banking
- Identity Theft
- DJIA
- Debt Management
- Loans
- Auto Loan
- Mortgages
- Taxes
- Retirement
- Insurance
- Small Business
- Earnings
- Tech News
- Tax Forms
- Tax Deductions
- Tax Credit
- Tax Audit
- Tax Advice
- Stock Ticker
- Stock Brokers
- Resume Builder
- Pig Flu
- Online Tax Filing
- Madoff
- Investing For Retirement
- Income Tax
- Historical Stock Prices
- GOOG
- ETF Investing
- Deals
- DailyFinance
- Crude Oil Prices
- Credit Score Calculator
- Common Tax Filing Mistakes
- AMT
BioHealth Investor Headlines
- Can Human Genome Really Double Its Stock Price? (HGSI)
- Alimera Implosion Analysis, What Is Next (ALIM, PSDV)
- Implosion Analysis For Targacept… What Lies Ahead? (TRGT, AZN)
- Rare Analyst Calls With Huge Upside in Vical and VIVUS (VICL, VVUS, BMY)
- Top Biotechs With Upside Ahead of Earnings (GILD, AMLN, ARIA, INCY, JAZZ, DNDN, HGSI, ILMN, AMGN, CELG, BIIB, BMRN, LIFE, REGN, AMLN, CBST, ONXX, THRX, VPHM)
The Money Man Behind Rick Santorum: Who Is Foster S. Friess?
Savings Experiment: Snow Removal

